AIRDF.US Rocket Doctor AI Inc.
- Market cap
- USD 32.1M
- P/E
- -
- P/B
- 123.20x
- ROE
- -6,291.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is AIRDF.US undervalued?
Graham numberThe Graham number of Rocket Doctor AI Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Rocket Doctor AI Inc. fundamental analysis
No fundamental analysis for Rocket Doctor AI Inc. yet.
Rocket Doctor AI Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare infor…
Full company profileRocket Doctor AI Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Rocket Doctor AI Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 11.0K | 1.74M | 2.94M |
| Gross Profit | - | - | - | 11.0K | 1.51M | 2.06M |
| Operating Income | -13.9M | -3.79M | -2.33M | -6.02M | -13.3M | -22.0M |
| EBITDA | - | -3.74M | -3.65M | -7.52M | -14.0M | -20.3M |
| Net Income | -13.9M | -3.80M | -3.72M | -7.55M | -15.7M | -22.6M |
| EPS | -2.10 | -0.57 | -0.10 | -0.15 | -0.18 | -0.23 |
| Balance Sheet | ||||||
| Total Assets | 943K | 13.7K | 739K | 1.28M | 10.6M | 10.2M |
| Total Liabilities | 833K | 2.20M | 1.48M | 486K | 7.13M | 9.82M |
| Shareholders' Equity | 110K | -2.19M | -738K | 793K | 3.51M | 360K |
| Cash & Short-term Investments | 917K | 2.50K | 716K | 1.23M | 642K | 948K |
| Cash Flow | ||||||
| Operating Cash Flow | -6.29M | -1.46M | -740K | -4.44M | -6.55M | -12.6M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 6.58K | 34.3K |
| Free Cash Flow | -6.29M | -1.46M | -740K | -4.44M | -6.56M | -12.6M |
| Ratios | ||||||
| ROE | -12,615.7% | - | - | -952.8% | -446.7% | -6,291.6% |
| ROA | -1,471.0% | -27,766.2% | -503.5% | -590.5% | -147.5% | -222.2% |
| Net Profit Margin | - | - | - | -68,731.5% | -902.1% | -768.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Rocket Doctor AI Inc. dividends
Rocket Doctor AI Inc. has not paid dividends in the last 5 fiscal years.
Last stock split: 1:10 on Jul 14, 2023.
Who owns Rocket Doctor AI Inc.
- Insiders 3.55%
- Institutions 0.23%
- Public & others 96.22%
- Shares outstanding 102M
- Free float 36.5M
Rocket Doctor AI Inc. company profile
- Company name
- Rocket Doctor AI Inc.
- Ticker
- AIRDF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Information Services
- Fiscal year end
- December
- Address
- 700-838 West Hastings Street, Vancouver, BC, Canada, V6C 0A6
- Phone
- 778-819-8321
- Website
- rocketdoctor.ai
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Rocket Doctor AI Inc. management
6- Dr. Essam Hamza M.D.CEO & Director · born 1971
- Mr. On Kwok Lau C.A., CPAChief Financial Officer · born 1966
- Mr. Richard AtkinsChief Operating Officer
- Dr. Robert Scott M.D.Chief Innovation Officer
- Ms. Kelly PladsonCorporate Secretary · born 1983
- Dr. William Cherniak M.D., M.P.H.Founder & CEO of Rocket Doctor